| Ident. | Authors (with country if any) | Title |
|---|
| 000844 (2013) |
| Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). |
| 000897 (2013) |
Daniel J. Burdick [États-Unis] ; Alida Griffith ; Pinky Agarwal | Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa. |
| 000B23 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000E62 (2012) |
Mayumi Kitagawa ; Hideki Houzen ; Kunio Tashiro | Caffeine in Parkinson's disease: comment on its importance and the dose proposal. |
| 001157 (2012) |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
| 001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
| 001684 (2011) |
Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine |
| 001689 (2011) |
Stuart A. Yablon [États-Unis] ; Mitchell F. Brin [États-Unis] ; Amanda M. Vandenburgh [États-Unis] ; Jihao Zhou [États-Unis] ; Susan M. Garabedian-Ruffalo [États-Unis] ; Susan Abu-Shakra [États-Unis] ; Frederick C. Beddingfield Iii [États-Unis] | Dose response with onabotulinumtoxinA for post‐stroke spasticity: A pooled data analysis |
| 001706 (2011) |
Jee-Young Lee [Corée du Sud] ; Jinwhan Cho [Corée du Sud] ; Eun-Kyung Lee [Corée du Sud] ; Sung-Sup Park [Corée du Sud] ; Beom S. Jeon [Corée du Sud] | Differential genetic susceptibility in diphasic and peak‐dose dyskinesias in Parkinson's disease |
| 001770 (2011) |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 001857 (2011) |
| Twice-Daily, Low-Dose Pramipexole in Early Parkinson's Disease: A Randomized, Placebo-Controlled Trial |
| 001938 (2010) |
Tanya Simuni [États-Unis] ; Emily Borushko [États-Unis] ; Michael J. Avram [États-Unis] ; Scott Miskevics [États-Unis] ; Audrey Martel [États-Unis] ; C. Zadikoff [États-Unis] ; Aleksandar Videnovic [États-Unis] ; Frances M. Weaver [États-Unis] ; Karen Williams [États-Unis] ; D. James Surmeier [États-Unis] | Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study |
| 001981 (2010) |
Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Richard Gray [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of levodopa dose equivalency reporting in Parkinson's disease |
| 001A29 (2010) |
Caspar Stephani [Allemagne] ; Claudia Trenkwalder [Allemagne] | Rhabdomyolysis after low‐dose quetiapine in a patient with Parkinson's disease with drug‐induced psychosis: A case report |
| 001B37 (2010) |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
| 001C53 (2010) |
Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon] | Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe? |
| 001D77 (2010) |
William G. Ondo [États-Unis] ; Lina Shinawi [États-Unis] ; Steven Moore [États-Unis] | Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single‐dose, double‐blind, double‐dummy, placebo‐controlled, crossover trial |
| 002198 (2009) |
A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schröder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne] | Muscle biopsy substantiates long‐term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers |
| 002508 (2009) |
A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne] | Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers |
| 002B67 (2007) |
Penelope Hogarth [États-Unis] ; Luca Lovrecic [États-Unis] ; Dimitri Krainc [États-Unis] | Sodium phenylbutyrate in Huntington's disease: A dose‐finding study |
| 002C71 (2007) |
Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon] | Placebo‐controlled, double‐blind dose‐finding study of entacapone in fluctuating parkinsonian patients |
